Patent intelligence · US
US 12116596
Method and apparatus for improved mesenchymal stem cell harvesting
Method and apparatus for improved mesenchymal stem cell harvesting
Patent details — US 12116596
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 15, 2024
- Expiration
- Oct 10, 2044
- Applicant
- Elite IP, LLC
- Claims
- 31
- CPC classes
- A61K, A61K35/28, A61K35/32
Quick answer
US 12116596 (Method and apparatus for improved mesenchymal stem cell harvesting) is held by Elite IP, LLC. Status: granted. Granted Oct 15, 2024. Expires Oct 10, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Elite IP, LLC
- Grant date
- Expiration
- Claims
- 31
- CPC classes
- A61K, A61K35/28, A61K35/32
More from Elite IP, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12364693
Methods of treating metabolic diseases with fused bicyclic pyrazoles
granted -
US 12295394
Water-soluble additive composition
granted -
US 12016853
Methods of treating RBP4 related diseases with triazolopyridines
granted -
US 11951100
Formulations of RBP4 inhibitors and methods of use
granted -
US 11723873
Oral dosage form of ticagrelor and preparation method thereof
granted -
US 11684596
Antidiabetic pharmaceutical compositions and preparation method thereof
granted -
US 11655454
Method and apparatus for improved mesenchymal stem cell harvesting
granted
Frequently asked questions
What is US patent 12116596?
US 12116596 (Method and apparatus for improved mesenchymal stem cell harvesting) is held by Elite IP, LLC. Status: granted. Granted Oct 15, 2024. Expires Oct 10, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12116596?
Elite IP, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 26 pharmaceutical patents for this assignee.
When does US 12116596 expire?
Our index shows an expiration date of Oct 10, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.